Eoin Brennan

10.1k total citations · 1 hit paper
52 papers, 1.8k citations indexed

About

Eoin Brennan is a scholar working on Molecular Biology, Immunology and Nutrition and Dietetics. According to data from OpenAlex, Eoin Brennan has authored 52 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 14 papers in Immunology and 12 papers in Nutrition and Dietetics. Recurrent topics in Eoin Brennan's work include Fatty Acid Research and Health (12 papers), Chronic Kidney Disease and Diabetes (7 papers) and Liver Disease Diagnosis and Treatment (6 papers). Eoin Brennan is often cited by papers focused on Fatty Acid Research and Health (12 papers), Chronic Kidney Disease and Diabetes (7 papers) and Liver Disease Diagnosis and Treatment (6 papers). Eoin Brennan collaborates with scholars based in Ireland, United Kingdom and Australia. Eoin Brennan's co-authors include Catherine Godson, Phillip Kantharidis, Mark E. Cooper, Patrick J. Guiry, Bo Wang, Sharon D. Ricardo, Junli Zhuang, Denise M. Sadlier, Jennifer L. Wilkinson‐Berka and Andrea F. Wise and has published in prestigious journals such as Circulation Research, Analytical Chemistry and Advanced Drug Delivery Reviews.

In The Last Decade

Eoin Brennan

51 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mesenchymal Stem Cells Deliver Exogenous MicroRNA-let7c via Exosomes to Attenuate Renal Fibrosis

2016 320 citations Bo Wang, Brooke M. Huuskes et al. Molecular Therapy profile →

Peers

Countries citing papers authored by Eoin Brennan

Since Specialization

Citations

This map shows the geographic impact of Eoin Brennan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eoin Brennan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eoin Brennan more than expected).

Fields of papers citing papers by Eoin Brennan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eoin Brennan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eoin Brennan. The network helps show where Eoin Brennan may publish in the future.

Co-authorship network of co-authors of Eoin Brennan

This figure shows the co-authorship network connecting the top 25 collaborators of Eoin Brennan. A scholar is included among the top collaborators of Eoin Brennan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eoin Brennan. Eoin Brennan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	TRIB3 Links Endoplasmic Reticulum Stress to Impaired Efferocytosis in Atherosclerosis 2025 ·Circulation Research ·(unknown), (unknown), (unknown), (unknown), Christopher G. Bell, (unknown), Thomas D. Nightingale, Monica de Gaetano, Orina Belton, Eoin Brennan, Patricia B. Munroe, Catherine Godson, Mary Barry, Carol C. Shoulders, Heather L. Wilson, Guillermo Velasco, Endré Kiss-Toth, Manikandan Subramanian	0
2	Lipoxin A4 improves cardiac remodeling and function in diabetes-associated cardiac dysfunction 2024 ·Cardiovascular Diabetology ·(unknown), Muthukumar Mohan, (unknown), Eoin Brennan, Helen Kiriazis, Minh Deo, Cameron J. Nowell, Catherine Godson, Mark E. Cooper, Peishen Zhao, Barbara K. Kemp‐Harper, Owen L. Woodman, Rebecca H. Ritchie, Phillip Kantharidis, Cheng Xue Qin	5
3	Mitochondrial related variants associated with cardiovascular traits 2024 ·Frontiers in Physiology ·Marisa Cañadas‐Garre, (unknown), (unknown), Claire Hill, (unknown), (unknown), Eoin Brennan, Ross Doyle, Catherine Godson, Alexander P. Maxwell, Amy Jayne McKnight	5
4	Treatment with lipoxin A4 improves influenza A infection outcome, induces macrophage reprogramming, anti-inflammatory and pro-resolutive responses 2024 ·Inflammation Research ·(unknown), (unknown), (unknown), (unknown), (unknown), Juliana P. Vago, (unknown), (unknown), Geovanni Dantas Cassali, Monica de Gaetano, Eoin Brennan, (unknown), Patrick J. Guiry, Catherine Godson, John F. Alcorn, Mauro Martins Teixeira	4
5	Decoding microRNA drivers in atherosclerosis 2022 ·Bioscience Reports ·(unknown), (unknown), Eoin Brennan	23
6	Pro-resolving lipid mediators: regulators of inflammation, metabolism and kidney function 2021 ·Nature Reviews Nephrology ·Eoin Brennan, Phillip Kantharidis, Mark E. Cooper, Catherine Godson	160
7	Extracellular vesicles from monocyte/platelet aggregates modulate human atherosclerotic plaque reactivity 2021 ·Journal of Extracellular Vesicles ·Silvia Oggero, Monica de Gaetano, Simone Marcone, Stephen Fitzsimons, Andreia Pinto, (unknown), Mary Barry, David F. Burke, Trinidad Montero‐Melendez, Dianne Cooper, Thomas Burgoyne, Orina Belton, Lucy V. Norling, Eoin Brennan, Catherine Godson, Mauro Perretti	49
8	Therapeutic potential of the FPR2/ALX agonist AT-01-KG in the resolution of articular inflammation 2021 ·Pharmacological Research ·Izabela Galvão, (unknown), Vívian Louise Soares de Oliveira, Juliana P. Vago, Celso Martins Queiroz‐Junior, Monica de Gaetano, Eoin Brennan, (unknown), Patrick J. Guiry, Catherine Godson, Mauro Martins Teixeira	32
9	Characterization of the renal cortical transcriptome following Roux-en-Y gastric bypass surgery in experimental diabetic kidney disease 2020 ·BMJ Open Diabetes Research & Care ·Meera G. Nair, William P. Martin, Vadim Zhernovkov, Jessie A. Elliott, Naomi Fearon, (unknown), Janet McCormack, Catherine Godson, Eoin Brennan, (unknown), Lars Fändriks, Neil G. Docherty, Carel W. le Roux	11
10	Diagnostic utility of genetic testing in patients undergoing renal biopsy 2020 ·Molecular Case Studies ·Katherine A. Benson, Susan Murray, Ross Doyle, Brendan Doyle, Anthony Dorman, Denise M. Sadlier, Eoin Brennan, Margaret Large, Gianpiero L. Cavalleri, Catherine Godson, Peter J. Conlon	8
11	microRNA-155 Is Decreased During Atherosclerosis Regression and Is Increased in Urinary Extracellular Vesicles During Atherosclerosis Progression 2020 ·Frontiers in Immunology ·Stephen Fitzsimons, Silvia Oggero, Robyn Bruen, Cathal McCarthy, Moritz J. Strowitzki, Niall Mahon, Nicola Ryan, Eoin Brennan, Mary Barry, Mauro Perretti, Orina Belton	39
12	Liraglutide Attenuates Preestablished Atherosclerosis in Apolipoprotein E–Deficient Mice via Regulation of Immune Cell Phenotypes and Proinflammatory Mediators 2019 ·Journal of Pharmacology and Experimental Therapeutics ·Robyn Bruen, (unknown), (unknown), (unknown), M. O'Reilly, Eugène Dillon, Eoin Brennan, Mary Barry, Stephen Sheehan, Fiona C. McGillicuddy, Orina Belton	43
13	Asymmetric synthesis and biological evaluation of imidazole- and oxazole-containing synthetic lipoxin A4 mimetics (sLXms) 2018 ·European Journal of Medicinal Chemistry ·Monica de Gaetano, (unknown), (unknown), (unknown), (unknown), Jianmin Chen, (unknown), Emily Hams, (unknown), (unknown), Eoin Brennan, Xavier Leroy, Christine E. Loscher, Padraic G. Fallon, Mauro Perretti, Catherine Godson, Patrick J. Guiry	43
14	Specialized Pro-resolving Lipid Mediators: Modulation of Diabetes-Associated Cardio-, Reno-, and Retino-Vascular Complications 2018 ·Frontiers in Pharmacology ·Monica de Gaetano, Caitríona M. McEvoy, Darrell Andrews, (unknown), (unknown), Eoin Brennan, Catherine Godson	29
15	Profibrotic IHG-1 complexes with renal disease associated HSPA5 and TRAP1 in mitochondria 2017 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·(unknown), Brenda Walker Griffin, Eoin Brennan, (unknown), Debra F. Higgins, Madeline Murphy	12
16	Specialized pro-resolving mediators in renal fibrosis 2017 ·Molecular Aspects of Medicine ·Eoin Brennan, (unknown), Catherine Godson	26
17	Mesenchymal Stem Cells Deliver Exogenous MicroRNA-let7c via Exosomes to Attenuate Renal Fibrosis breakdown → 2016 ·Molecular Therapy ·Bo Wang, (unknown), Brooke M. Huuskes, Hsin‐Hui Shen, Junli Zhuang, Catherine Godson, Eoin Brennan, Jennifer L. Wilkinson‐Berka, Andrea F. Wise, Sharon D. Ricardo	320
18	Paricalcitol protects against TGF-β1-induced fibrotic responses in hypoxia and stabilises HIF-α in renal epithelia 2014 ·Experimental Cell Research ·Karen A. Nolan, Eoin Brennan, Carsten C. Scholz, (unknown), (unknown), Cormac T. Taylor, Catherine Godson	21
19	Lipoxins Attenuate Renal Fibrosis by Inducing let-7c and Suppressing TGFβR1 2013 ·Journal of the American Society of Nephrology ·Eoin Brennan, Karen A. Nolan, Emma Börgeson, (unknown), Caitríona M. McEvoy, Neil G. Docherty, Debra F. Higgins, Madeline Murphy, Denise M. Sadlier, Syed Tasadaque Ali Shah, Patrick J. Guiry, David A. Savage, Alexander P. Maxwell, Finian Martin, Catherine Godson	138
20	Next-generation sequencing identifies TGF-β1-associated gene expression profiles in renal epithelial cells reiterated in human diabetic nephropathy 2012 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Eoin Brennan, Melissa J. Morine, David Walsh, Sarah Roxburgh, Maja T. Lindenmeyer, Derek P. Brazil, Peadar Ó Gaora, Helen M. Roche, Denise M. Sadlier, Clemens D. Cohen, Catherine Godson, Finian Martin	67

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact